,

Stability of Protein Pharmaceuticals

Part B: In Vivo Pathways of Degradation and Strategies for Protein Stabilization

Specificaties
Gebonden, 328 blz. | Engels
Springer US | 1992e druk, 1992
ISBN13: 9780306441530
Rubricering
Springer US 1992e druk, 1992 9780306441530
Onderdeel van serie Pharmaceutical Biotechnology
€ 240,99
Levertijd ongeveer 8 werkdagen

Samenvatting

Part B explores protein degradation occuring in vivo during protein synthesis in cells, examines the isolation and purification of proteins, details protein use in organisms, and reviews techniques to enhance protein stability.

Specificaties

ISBN13:9780306441530
Taal:Engels
Bindwijze:gebonden
Aantal pagina's:328
Uitgever:Springer US
Druk:1992

Inhoudsopgave

Improper Glycosylation and the Cellular Editing of Nascent Proteins; D.A. Cumming. Protein Aggregation In Vivo; R. Wetzel. Pathways of Intracellular Protein Degradation in Eukaryotic Cells; T.S. Olson, et al. Effects of Aging on Proteins; R.W. Gracy. Engineering Dramatic Increases in the Stability of Subtilisin; P.N. Bryan. Increased Stability of Mutant Forms of Yeast Cytochrome c; D.R. Hickey, et al. Introduction to Formulation of Protein Pharmaceuticals; M.A. Hanson, S.K.E. Rouan. PEG Modified Proteins; G.E. Francis, et al. Stabilization of Protein Structure by Solvent Additives; S.N. Timasheff. Heat-Shock Proteins and their Potential Uses for Pharmaceutical Protein Production in Microorganisms; J.M. McCoy. Index.
€ 240,99
Levertijd ongeveer 8 werkdagen

Rubrieken

    Personen

      Trefwoorden

        Stability of Protein Pharmaceuticals